Godrej Industries Q3 FY26: Income up 11%, EBITDA 20%

Key takeaway from the board-approved results

Godrej Industries Limited announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, after board approval on February 11, 2026. The results were reviewed by the statutory auditors, and the company said the review conclusion was unmodified. The update showed year-on-year growth in consolidated income and operating profitability, while standalone performance turned into a quarterly loss. The company also disclosed exceptional items tied to additional employee benefit liabilities following new labour codes notified by the Government of India. Segment commentary pointed to momentum in chemicals, real estate, agri businesses, and select sub-segments such as animal feed, crop protection, and vegetable oils.

Consolidated performance: income growth and stronger operating profit

For Q3 FY26, consolidated total income rose 11% year-on-year to ₹5,697.59 crore, compared with ₹5,146.88 crore in Q3 FY25. Revenue from operations for the quarter increased 5% to ₹5,051.19 crore from ₹4,824.83 crore. Operating profitability expanded faster than income, with PBDIT (EBITDA) up 20% year-on-year to ₹1,238.00 crore from ₹1,033.00 crore. PBIT for Q3 FY26 was reported at ₹1,112 crore, up 21% year-on-year, reflecting stronger operating leverage in the period. The company also reported a Q3 FY26 operating margin of 10.79% and a net profit margin of 4.55%.

Nine-month trend: double-digit income growth, higher PBDIT and PBIT

For the nine months ended December 31, 2025, consolidated total income increased 14% year-on-year to ₹17,706.25 crore, versus ₹15,524.51 crore in the prior-year period. Over the same period, PBDIT rose 28% to ₹4,414 crore and PBIT increased 29% to ₹4,054 crore. The company’s executive summary also stated that nine-month net profit was stable at ₹796 crore. In the same material set, the company’s consolidated EPS (basic) for Q3 FY26 was cited at ₹6.07, up from ₹5.59 a year earlier.

Profit figures: what the disclosures show

The provided disclosures include more than one net profit figure for Q3 FY26. One section stated net profit for Q3 FY26 increased 9% year-on-year to ₹205 crore, while another table in the same material cited consolidated net profit of ₹352.68 crore for Q3 FY26 versus ₹312.40 crore in Q3 FY25. Separately, a Q&A-style snippet mentioned “net profit of Rs 241” for Q3 FY25-26 without additional context in the excerpt. These figures appear in the supplied text, and the company’s detailed financial statements and exchange filings remain the reference point for the final reported line items.

Costs and finance line: interest expense moved higher

Interest expenses were reported at ₹626 crore in Q3 FY26 and ₹1,786 crore for 9M FY26. The disclosures also note exceptional items of ₹63.77 crore in consolidated results for Q3 FY26, linked to additional gratuity and leave benefits liability arising from new labour codes. Such items can affect comparability across periods, especially when operating profit trends remain strong but reported profit lines differ depending on exceptional and other non-operating elements.

Standalone results: revenue rose, but the quarter reported a loss

Standalone operations showed a contrasting picture in Q3 FY26. Revenue from operations increased 20% year-on-year to ₹1,226.97 crore from ₹1,022.89 crore. However, the company reported a net loss of ₹21.05 crore for Q3 FY26 compared with a profit of ₹0.20 crore in Q3 FY25. For the nine months ended December 31, 2025, standalone profit before tax was reported at ₹47.98 crore. Total standalone expenses for Q3 FY26 were ₹1,315.03 crore, up from ₹1,050.73 crore a year earlier.

Segment check: Chemicals, Real Estate, and Agri in focus

Chemicals revenue for Q3 FY26 was reported at ₹1,092 crore, up 23% year-on-year, and nine-month revenue at ₹3,033 crore, up 24%. Exports were said to contribute around 28% of chemicals revenue, highlighting an external demand component within the mix. In Real Estate, Q3 FY26 total income was cited at ₹1,020 crore, with net profit at ₹195 crore, and booking value growth of 55% year-on-year. In the Agri Business, Q3 FY26 total income increased to ₹2,737 crore from ₹2,458 crore, while net profit for the quarter was reported at ₹115 crore.

Consumer Products and other sub-segments: growth with pressure points

The Consumer Products segment was described as showing 9% year-on-year sales growth in Q3 FY26. The same segment also saw net profit decline 14% year-on-year when excluding one-offs, as per the supplied summary. The company also highlighted robust volume and revenue growth in Animal Feed and Crop Protection, and referenced strength in vegetable oils as part of the diversified portfolio’s performance narrative.

Corporate actions and portfolio moves disclosed for 9M FY26

During the nine months ended December 31, 2025, the company said it incorporated a wholly owned subsidiary, Godrej Investment Limited, with an investment of ₹3,862.70 crore. It also disclosed the subsequent divestment of Godrej Capital Limited to this new subsidiary. Separately, Godrej Agrovet Limited, a subsidiary, completed the acquisition of the remaining equity stake in Creamline Dairy Products Limited, as noted in the provided text.

Key numbers at a glance

Market and governance context mentioned in the disclosures

The company said the board meeting to consider and approve the unaudited results was held on February 11, 2026, following Audit Committee review, and that the disclosures were made in compliance with SEBI regulations via BSE and NSE. A separate excerpt also referenced differing “upcoming earnings date” entries for the company, including February 11, 2026 and August 13, 2025, as presented in the supplied text. On capital structure-related disclosures included in the broader material, the company’s report mentioned privately placed non-convertible debentures of ₹1,500 crore during FY 2024-25 and ₹1,000 crore during FY 2025-26 (till the date of that report). It also noted that NCDs of ₹750 crore were redeemed on May 14, 2025, and that aggregate outstanding NCDs were stated at ₹5,200 crore as on the date of that report.

Why this quarter matters for investors tracking Godrej Industries

The Q3 FY26 disclosures combine two signals that investors typically track closely in diversified holding companies: steady consolidated income growth alongside higher operating profit, and volatility at the standalone level due to cost and exceptional items. Segment-level numbers point to strong momentum in chemicals and improved performance in real estate and agri businesses during the quarter. At the same time, the finance cost line and exceptional items disclosure are important for understanding reported profit outcomes. The portfolio actions disclosed for 9M FY26 also show internal restructuring and consolidation moves that can influence how earnings streams are organised across subsidiaries.

Conclusion

Godrej Industries’ Q3 FY26 update showed consolidated income growth of 11% year-on-year and a 20% rise in PBDIT, alongside a standalone quarterly loss and disclosed exceptional items tied to new labour code-related liabilities. The next formal milestones will be subsequent exchange filings and scheduled board and results updates as announced by the company.